Defining Success in IBD: Treat-to-Target
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Where Conventional IBD Therapies Fall Short
Michael Dolinger, MD, MBA
IBD Care Reimagined: Personalized, Proactive, and Target-Driven Management
David T. Rubin, MD
The Future of Biologic Treatment in IBD: What’s on the Horizon
Setting the Stage: Why Rethinking IBD Care Matters Now
Navigating IBD Guidelines: What Clinicians Need to Know Now
Small Molecules in IBD: JAK Inhibitors and S1P Modulators
Translating Advances into Practice: Lessons from Today’s IBD Landscape
Putting It All Together: Challenges Addressed
IBD Beyond Symptoms: What Community GIs Need to Know
Targeting Inflammation in IBD: Localized vs Systemic Strategies
IBD Masterclass: Foundations of Pathophysiology and Targeted Therapy
Genetic Susceptibility in IBD: From Risk Genes to Clinical Impact
Case Review: Targets Are Met—Can You Stick the Landing?
David Rubin, MD
Jennifer Geremia, PA-C
Case Review: Can You Crack This IBD Case?
Kimberly D. Orleck, PA-C
IBD Immunopathogenesis: Do You Know What You're Blocking?
Brooke Hodnick, PA-C, MPAS
Loading...
We're glad to see you're enjoying Crohn's Colitis Professional… but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.